Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 224

Similar articles for PubMed (Select 16750326)

1.

Comparison of biochemical failure definitions for permanent prostate brachytherapy.

Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Zelefsky MJ, Pisansky TM, Elshaikh M, Horwitz EM.

Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1487-93. Epub 2006 Jun 5.

PMID:
16750326
2.

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

Thames H, Kuban D, Levy L, Horwitz EM, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A.

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):929-43.

PMID:
14575823
3.

Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation.

Fitch DL, McGrath S, Martinez AA, Vicini FA, Kestin LL.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1430-9. Epub 2006 Jun 12.

PMID:
16765527
4.

Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?

Kuban D, Thames H, Levy L, Horwitz E, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):409-14.

PMID:
15667960
5.

Practical application of biochemical failure definitions: what to do and when to do it.

Kestin LL, Vicini FA, Martinez AA.

Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):304-15.

PMID:
12023134
6.

Prostate-specific antigen spikes after permanent prostate brachytherapy.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):450-6.

PMID:
12243821
7.

Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis.

Horwitz EM, Thames HD, Kuban DA, Levy LB, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Hanks GE, Zietman AL.

J Urol. 2005 Mar;173(3):797-802.

PMID:
15711272
9.

Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.

Mitchell DM, Swindell R, Elliott T, Wylie JP, Taylor CM, Logue JP.

Radiother Oncol. 2008 Jul;88(1):102-7. doi: 10.1016/j.radonc.2008.04.004. Epub 2008 Apr 29.

PMID:
18453022
10.

PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.

Ciezki JP, Reddy CA, Garcia J, Angermeier K, Ulchaker J, Mahadevan A, Chehade N, Altman A, Klein EA.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):512-7. Epub 2005 Oct 6.

PMID:
16213667
11.

Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy.

Cheung R, Tucker SL, Lee AL, Dong L, Kamat A, Pisters L, Kuban DA.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):14-9.

PMID:
15629589
12.
13.

The impact of irregularly rising prostate-specific antigen and "impending failure" on the apparent outcome of localized prostate cancer following radiotherapy.

Hodgson DC, Catton CN, Warde P, Gospodarowicz MK, Milosevic MF, McLean M B M, Catton P.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):957-63.

PMID:
11240236
14.
15.

Definitions of biochemical failure in prostate cancer following radiation therapy.

Taylor JM, Griffith KA, Sandler HM.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1212-9.

PMID:
11483331
16.

Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.

Stock RG, Stone NN, Cesaretti JA.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):448-53.

PMID:
12738319
17.

Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy.

Merrick GS, Butler WM, Wallner KE, Lief JH, Hinerman-Mulroy A, Galbreath RW.

Brachytherapy. 2003;2(3):181-8.

PMID:
15062141
18.

PSA bounce predicts early success in patients with permanent iodine-125 prostate implant.

Patel C, Elshaikh MA, Angermeier K, Ulchaker J, Klein EA, Chehade N, Wilkinson DA, Reddy CA, Ciezki JP.

Urology. 2004 Jan;63(1):110-3.

PMID:
14751360
19.

Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy.

Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):993-1002.

PMID:
15752878
20.

Importance of implant dosimetry for patients undergoing prostate brachytherapy.

Potters L, Huang D, Calugaru E, Fearn P, Lee L, Kattan MW.

Urology. 2003 Dec;62(6):1073-7.

PMID:
14665358
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk